Bernard L Silverman (Bernard Silverman)

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Peritoneal Dialysis

Alcohol Consumption

Top Venues

Alcoholism, clinical and experimental research

Neuropsychiatric disease and treatment

Addiction (Abingdon, England)

Alkermes (United States)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Alkermes (United States)

United States

VP Clinical Strategy :: Medicines Development

Publications

Citrome Leslie, Christine Graham, Adam Simmons, Ying Jiang, Mark S Todtenkopf, Bernard L Silverman, Lauren DiPetrillo, Hannah Cummings, Lei Sun, David McDonnell
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder. Neuropsychiatric disease and treatment 17 (2021)
Edward V Nunes, Adam Bisaga, Evgeny M Krupitsky, Narinder Nangia, Bernard L Silverman, Sarah C Akerman, Maria A Sullivan
Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism. Addiction (Abingdon, England) 115 (2) (2019)
Stephanie S O'Malley, Mark S Todtenkopf, Yangchun Du, Elliot Ehrich, Bernard L Silverman
Effects of the Opioid System Modulator, Samidorphan, on Measures of Alcohol Consumption and Patient-Reported Outcomes in Adults with Alcohol Dependence. Alcoholism, clinical and experimental research 42 (10) (2018)
Bernard L Silverman, Gary Bloomgren, Priya Jain, Kimberley Marcopul, Alexandra Silveira, James Fratantonio, Maria Sullivan, Sarah Akerman
Comment on "Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence". Drug safety 41 (10) (2018)